DORSEY PAUL: Open Payments
NPI 1750392023 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,171 in 113 payments from 13 companies in 2025. Trend: 2023 $1,744 · 2024 $1,307 · 2025 $6,171
Long term medical supply or device loan: $4,768Food & beverage: $1,403
| Company | Payments | Amount |
|---|---|---|
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 2 | $4,783 |
| Collegium Pharmaceutical, Inc. | 26 | $213 |
| Forte Bio-Pharma LLC | 16 | $211 |
| PROTEGA PHARMACEUTIALS INC | 18 | $188 |
| PFIZER INC. | 23 | $175 |
| ABBVIE INC. | 11 | $166 |
| Axsome Therapeutics, Inc. | 5 | $165 |
| Averitas Pharma Inc. | 3 | $80 |
| Lundbeck LLC | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
Products named: RS-4i Plus with Intersperse, PROLATE, ROXYBOND, Symbravo, NURTEC ODT, Belbuca, QULIPTA, QUTENZA.
Industry payments across KS — which companies pay providers there.
